Treatment of sepsis and septic shock using ghrelin and growth hormone
US8324151B2 · kind B2 · utility
5Cited by
3References
13Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 14, 2008 |
| Grant date | Dec 4, 2012 |
| Priority date | — |
| Expiry date | Oct 25, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods are disclosed for treating sepsis and septic shock using a combination of ghrelin and growth hormone, and for using ghrelin to reduce organ and tissue injury and improve survival after combined radiation exposure and sepsis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.